Publication | Closed Access

In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus

Hepatitis CViral HepatitisImmunologyAntiviral TherapyHepatitisVirologyAntiviral ResponseAntibody EngineeringMedicineCross-reactive AntibodiesHypervariable Region 1Vitro Evidence